PTHL - Total Utang marang Modal Pheton Holdings

Logo perusahaan publik Pheton Holdings Limited (PTHL)

The market trend for Pheton Holdings Ltd (PTHL) shares demonstrates a dependence on the implementation of tumor irradiation software in China, with the individual debt-to-equity ratio standing at 0.03. The business relies on the supply of radiological systems and the service support of consumables. Growth is constrained by medical testing costs, stringent regulatory oversight, and specific lobbying within the Chinese region.

PTHL: Total Utang marang Modal Pheton 06.09.2024 - 16.01.2026
Barang utama Pheton Holdings

Investors are assessing the resilience of Pheton Holdings Ltd (PTHL) through the total liabilities-to-equity ratio, which determines the business's degree of dependence on debt financing. When analyzing changes in the debt-to-equity ratio, it is critical to understand how high software development costs and regulatory risks in China impact the debt load, balancing financial security against the efficiency of return on investment.

Analisis pesaing Pheton Holdings Ltd

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|ENTX (Entera Bio Ltd) - Utang Agregat marang Ekuitas|MindWalk - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ABVC (ABVC BioPharma, Inc)|CPIX: Total Utang marang Modal|Utang marang Modal quantumbiopharma.com (QNTM)|Rasio Total Utang marang Ekuitas FGEN|TELO (Telomir Pharmaceuticals Inc) - Utang Agregat marang Modal|Utang marang Ekuitas Rani Therapeutics (RANI)|SNYR - Utang marang Modal|Utang marang Ekuitas Rallybio RLYB|LEXX: Rasio Utang marang Ekuitas|PULM: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi APM (Aptorum Group Limited)|LYRA: Total Utang marang Modal|Impact BioMedical, Inc. - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas TNF Pharmaceuticals Inc.|Utang marang Modal cbdMD Corp YCBD|Utang marang Ekuitas PainReform (PRFX)|Utang marang Ekuitas CYTO (altamiratherapeutics.com)|Total Utang marang Modal LIPO (Lipella)|OPTN: Rasio Utang marang Ekuitas|Pieris Pharmaceuticals - Total Utang marang Modal|Koefisien Total Utang marang Modal procapsgroup.com PROC|Petros Pharmaceuticals, Inc. (PTPI) - Utang marang Ekuitas|Rasio Utang marang Ekuitas QLI|SLRN (ACELYRIN, Inc.) - Total Utang marang Modal|TFFP - Rasio Utang marang Modal